Updated Jul 16, 2026
MPM BioVentures 2014, L.P. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $6.18M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-12-04 | HOWL | Werewolf Therapeutics, Inc. | S — Open-market sale [10b5-1] | 83.2K | $0.97 | $81K |
| 2025-12-04 | HOWL | Werewolf Therapeutics, Inc. | S — Open-market sale [10b5-1] | 57.2K | $0.87 | $50K |
| 2025-12-04 | HOWL | Werewolf Therapeutics, Inc. | S — Open-market sale [10b5-1] | 59.3K | $0.89 | $53K |
| 2025-05-13 | ITOS | iTeos Therapeutics, Inc. | S — Open-market sale | 630.2K | $8.06 | $5.08M |
| 2024-12-12 | TRDA | Entrada Therapeutics, Inc. | S — Open-market sale | 21.8K | $20.23 | $441K |
| 2024-12-12 | TRDA | Entrada Therapeutics, Inc. | S — Open-market sale | 22.9K | $20.77 | $476K |
MPM BioVentures 2014, L.P. is a corporate insider — currently tracked as Insider. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 6 open-market sales ($6.18M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live MPM BioVentures 2014, L.P. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.